Company Metrics

• 20.37 P/E
• 2.45 P/S
• 4.48 P/B
• 1.08 EPS
• 46.47% Cash ROIC
• 1.71 Cash Ratio
• 1 / 4.55% Dividend
• 445,431.00 Avg. Vol.
• 56.64M Shares
• 1.259B Market Cap.

Company Description

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring products worldwide. The company offers Masimo Signal Extraction Technology SET), which provides the capabilities of measure-through motion and low perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry; and Masimo rainbow SET products that monitors multiple blood measurements, including carboxyhemoglobin, methemoglobin, pleth variability index, total hemoglobin, acoustic respiration rate, and Halo Index. It develops, manufactures, and markets a family of patient monitoring solutions, which incorporate a monitor or circuit board and sensors comprising proprietary single-patient use and reusable sensors, and cables. The company also offers patient SafetyNet, a remote monitoring and clinician notification system, and software. It sells its products to end users hospitals and the emergency medical response organizations through its direct sales force and distributors, as well as to original equipment manufacturer partners. The company was founded in 1989 and is headquartered in Irvine, California.
less

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring products worldwide. The company offers Masimo Signal Extraction Technology SET), which provides the capabilities of measure-through motion and low perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry; and Masimo rainbow SET products that monitor...
more

News